Low-Dose Propranolol and Bleomycin for Infantile Hemangioma (IH)

NACompletedINTERVENTIONAL
Enrollment

260

Participants

Timeline

Start Date

January 1, 2024

Primary Completion Date

January 1, 2025

Study Completion Date

January 1, 2025

Conditions
Infantile Hemangioma (IH)
Interventions
DRUG

Propranolol + Bleomycin

Oral propranolol at 1 mg/kg/day for 6 months plus intralesional bleomycin (1 mg/mL solution) injected once monthly. The bleomycin dose was 0.2-0.5 mg per injection site, not exceeding a total of 1 mg/kg per session or a cumulative dose of 10 mg.

DRUG

Propranolol

Oral propranolol hydrochloride solution administered at a dose of 1 mg/kg/day for 6 months.

Trial Locations (1)

430015

Wuhan Children's Hospital, Wuhan

All Listed Sponsors
lead

Wuhan Integrated Traditional Chinese and Western Medicine Hospital

OTHER

NCT07104526 - Low-Dose Propranolol and Bleomycin for Infantile Hemangioma (IH) | Biotech Hunter | Biotech Hunter